Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 17.04x is 15% below its 5-year average of 20.06x, near the low end of its 5-year range (5.42x–85.01x).
As of the fiscal period ended Tuesday, March 31, 2026. 63.47% above its 12-month average of 10.42x.
Reported quarterly interest coverage; no daily interpolation.
INTEREST COVERAGE RATIO
17.04x
INTEREST COVERAGE RATIO AVG TTM
10.42x
INTEREST COVERAGE RATIO AVG 3Y
23.69x
INTEREST COVERAGE RATIO AVG 5Y
14.68x
INTEREST COVERAGE RATIO AVG 10Y
17.74x
INTEREST COVERAGE RATIO AVG 15Y
17.90x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+63.47%
CURRENT VS 3Y AVG
-28.07%
CURRENT VS 5Y AVG
+16.09%
CURRENT VS 10Y AVG
-3.96%
CURRENT VS 15Y AVG
-4.83%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.77x
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
+151.68%
vs the sector median at left
Novo Nordisk A/S
Market Cap
$209.19B
Interest Coverage Ratio
17.04x
TTM Avg
10.42x
3Y Avg
23.69x
5Y Avg
14.68x
Market Cap
$207.87B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$213.42B
Interest Coverage Ratio
5.71x
TTM Avg
5.17x
3Y Avg
6.77x
5Y Avg
10.10x
Market Cap
$182.90B
Interest Coverage Ratio
23.60x
TTM Avg
17.46x
3Y Avg
17.67x
5Y Avg
16.77x
Market Cap
$161.66B
Interest Coverage Ratio
11.43x
TTM Avg
6.56x
3Y Avg
7.26x
5Y Avg
7.18x
Market Cap
$142.54B
Interest Coverage Ratio
5.78x
TTM Avg
5.55x
3Y Avg
10.96x
5Y Avg
11.04x
Market Cap
$137.13B
Interest Coverage Ratio
19.38x
TTM Avg
19.02x
3Y Avg
23.18x
5Y Avg
23.65x
Market Cap
$133.41B
Interest Coverage Ratio
8.41x
TTM Avg
6.69x
3Y Avg
7.04x
5Y Avg
6.41x
Market Cap
$133.25B
Interest Coverage Ratio
3.33x
TTM Avg
3.10x
3Y Avg
3.72x
5Y Avg
4.16x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novo Nordisk A/S (NVO) | $209.19B | 17.04x | 10.42x | 23.69x | 14.68x |
| Amgen Inc. (AMGN)vs › | $207.87B | 3.88x | 3.09x | 3.93x | 4.89x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $213.42B | 5.71x | 5.17x | 6.77x | 10.10x |
| Abbott Laboratories (ABT)vs › | $182.90B | 23.60x | 17.46x | 17.67x | 16.77x |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 11.43x | 6.56x | 7.26x | 7.18x |
| Pfizer Inc. (PFE)vs › | $142.54B | 5.78x | 5.55x | 10.96x | 11.04x |
| Danaher Corporation (DHR)vs › | $137.13B | 19.38x | 19.02x | 23.18x | 23.65x |
| Bristol-Myers Squibb Company (BMY)vs › | $133.41B | 8.41x | 6.69x | 7.04x | 6.41x |
| CVS Health Corp. (CVS)vs › | $133.25B | 3.33x | 3.10x | 3.72x | 4.16x |
| AstraZeneca PLC (AZN)vs › | $131.47B | 8.11x | 7.03x | 5.51x | 4.49x |
Interest Coverage
17.0x
Debt/Equity
0.67
Current Ratio
0.80
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 17.04x |
| 2025-06-30 | 6.75x |
| 2025-03-31 | 7.48x |
| 2024-12-31 | 7.21x |
| 2024-09-30 | 41.20x |
| 2024-06-30 | 16.60x |
| 2024-03-31 | 15.35x |
| 2023-12-31 | 29.22x |
| 2023-09-30 | 12.41x |
| 2023-06-30 | 85.01x |
| 2023-03-31 | 22.29x |
| 2022-12-31 | 23.39x |
| 2022-09-30 | 5.42x |
| 2022-06-30 | 5.66x |
| 2022-03-31 | 13.32x |
| 2021-12-31 | 17.45x |
| 2021-09-30 | 16.45x |
| 2021-03-31 | 18.80x |
| 2020-09-30 | 45.91x |
| 2020-06-30 | 26.66x |
| 2020-03-31 | 12.56x |
| 2019-09-30 | 15.58x |
| 2019-06-30 | 10.18x |
| 2019-03-31 | 13.82x |
| 2018-09-30 | 17.50x |
| 2018-06-30 | 16.38x |
| 2018-03-31 | 336.43x |
| 2017-09-30 | 463.23x |
| 2017-06-30 | 11.50x |
| 2017-03-31 | 18.13x |
| 2016-09-30 | 104.37x |
| 2016-06-30 | 1041.42x |
| 2016-03-31 | 32.48x |
| 2015-09-30 | 6.47x |
| 2015-06-30 | 6.45x |
| 2015-03-31 | 8.36x |
| 2014-09-30 | 19.43x |
| 2014-06-30 | 62.38x |
| 2014-03-31 | 25.26x |
| 2013-09-30 | 72.00x |
| 2013-06-30 | 32.15x |
| 2013-03-31 | 70.02x |
| 2012-09-30 | 15.57x |
| 2012-06-30 | 8.94x |
| 2012-03-31 | 17.03x |
| 2011-12-31 | 22.36x |
| 2011-09-30 | 18.21x |
| 2011-06-30 | 31.53x |
| 2011-03-31 | 25.56x |
| 2010-12-31 | 5.36x |
| 2010-09-30 | 10.74x |
| 2010-06-30 | 8.77x |
| 2010-03-31 | 22.47x |
| 2009-12-31 | 11.37x |
| 2009-09-30 | 18.25x |
| 2009-06-30 | 11.33x |
| 2009-03-31 | 9.25x |
| 2008-09-30 | 50.36x |
| 2008-03-31 | 7.69x |
